Growth Metrics

Sanara MedTech (SMTI) Return on Invested Capital (2022)

Sanara MedTech posted quarterly Return on Invested Capital of 0.0% for Q4 2022, up 59.17% on a QoQ basis from 0.0% in Q3 2022.

Sanara MedTech (SMTI) has 1 years of Return on Invested Capital data on file, last reported at 0.0% in Q4 2022.

  • For the quarter ending Q4 2022, Return on Invested Capital changed N/A year-over-year to 0.0%; the trailing twelve-month figure through Dec 2022 stood at 0.0% (changed N/A YoY), and the FY2022 full-year result was 0.0%, changed N/A from the prior year.
  • Return on Invested Capital for Q4 2022 stood at 0.0%, up from 0.0% in the prior quarter.
  • Across five years, Return on Invested Capital topped out at 0.0% in Q4 2022 and bottomed at 0.0% in Q2 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROIC (Qtr)
1 Intuitive Surgical 156.17 Bn 151.78 Bn 1.83 Bn 0.00%
2 Becton Dickinson 41.51 Bn 40.49 Bn 2.15 Bn 0.00%
3 Resmed 30.43 Bn 28.77 Bn 890.98 Mn 0.00%
4 West Pharmaceutical Services 22.78 Bn 22.26 Bn 296.40 Mn 0.00%
5 Solventum 13.39 Bn 13.39 Bn 1.10 Bn 0.00%
6 Cooper Companies 12.33 Bn 12.20 Bn 695.20 Mn 0.00%
7 Align Technology 11.65 Bn 10.59 Bn 736.59 Mn 0.00%
8 Baxter International 9.81 Bn 7.77 Bn 891.00 Mn 0.00%
9 Aptargroup 7.39 Bn 7.19 Bn 351.91 Mn 0.00%
10 Sanara MedTech 203.69 Mn 190.09 Mn 25.87 Mn -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2022 0.00%
Sep 30, 2022 0.00%
Jun 30, 2022 0.00%